FREE Breaking News Alerts from StreetInsider.com!
E-mail Address
Top NewsMost Read Highlighted
Get AlertsIMUC Hot Sheet
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: Up
Today’s Overall Ratings:
Earlier, Roth Capital initiated coverage on ImmunoCellular Therapeutics (NYSE: IMUC) with a Buy. PT $6.00.
For an analyst ratings summary and ratings history on ImmunoCellular Therapeutics click here. For more ratings news on ImmunoCellular Therapeutics click here.
Shares of ImmunoCellular Therapeutics closed at $2.03 yesterday, with a 52 week range of $0.98-$3.96.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items – JOIN NOW